Actively Recruiting
Quality of Life in School Aged-children With Posterior Urethral Valves
Led by Hospices Civils de Lyon · Updated on 2025-05-07
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Posterior urethral valves (PUV) are a common birth defect affecting the urethra in male children, potentially leading to kidney and bladder problems. This research aims to study the quality of life in school-aged boys who were treated for PUV during their first year of life, using the Pediatric Quality of Life Inventory Version 4.0 (PedsQL 4.0) to understand their well-being better. The study observes male children aged 6 to 17 years who received treatment for PUV in their infancy between 2006 and 2018 at the Femme-Mère-Enfant Hospital in Lyon. There is no intervention being administered; instead, participants are assessed to collect data on their quality of life scores at the time of inclusion. Participants will complete the PedsQL 4.0 questionnaire to measure their quality of life. The study focuses on how previous PUV treatment and related conditions affect their daily living and well-being. Researchers will analyze the scores to understand the impact of PUV on long-term quality of life, with no additional treatments or follow-up periods described.
CONDITIONS
Brief Title
Study of the Quality of Life in School Aged-children With Posterior Urethral Valves
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients and their parents or relatives
- Aged 6 to 17 years old
- Treated for posterior urethral valves in their first year of life between 2006 and 2018
- Managed in the Femme-Mère-Enfant Hospital in Lyon
You will not qualify if you...
- Children with severe cognitive or physical disabilities from other conditions as rated by a physician
- Children unable to complete the quality of life questionnaire due to mental or communication impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - At inclusion
Participants undergo assessments including quality of life questionnaires.
1 visit (in-person)
Duration - Up to study completion in August 2026
Participants are observed over time to assess quality of life outcomes.
Trial Site Locations
Total: 1 location
1
Femme-Mère-Enfant Hospital
Bron, Bron, France
Actively Recruiting
Research Team
B
BIDAULT Valeska, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here